Marathon Petroleum faces gasoline price lawsuit risk, shares stay firm in S&P 500 peer group
23.06.2026 - 17:31:59 | ad-hoc-news.deBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 17:26.
Marathon Petroleum (US56585A1025) appears in a new California lawsuit that accuses several fuel retailers of using artificial intelligence tools to coordinate and inflate gasoline prices, according to reporting from Reuters and Bloomberg. The company’s shares trade on the NYSE and remain near highs in the S&P 500 energy sector despite the legal headwind.
What Reuters and Bloomberg report
On 22 June 2026, Reuters reported that California’s attorney general filed a civil complaint against BP, Marathon, 7-Eleven and Walmart, alleging that they used third-party AI-driven pricing software to keep gasoline prices elevated in the state. The lawsuit claims the tools analyzed competitors’ prices and recommended increases that allegedly dampened competition, according to the court filing summarized in the coverage. Reuters details the California gasoline pricing lawsuit
Bloomberg reported the same day that the complaint seeks civil penalties and an injunction against the alleged conduct, focusing on the use of algorithmic tools in a concentrated fuel retail market. The reports state that the companies, including Marathon Petroleum, are accused rather than found liable, and the matter is expected to take time to work through the courts. Bloomberg summarizes the AI-based fuel pricing allegations
Analyst sentiment and recent performance
Despite the lawsuit headlines, Marathon Petroleum shares have held up in recent trading. On 22 June 2026, MarketBeat showed the stock at about 247 US dollars, up roughly 1.7 percent on the day in regular NYSE trading, with after-hours indications slightly higher. Data compiled by finanzen100 point to a strong one-year performance, placing the stock among notable gainers in the S&P 500 energy component.
Analyst commentary has remained constructive. Wells Fargo recently lifted its price target on Marathon Petroleum, as cited by finanzen100 citing U.S. analyst reports, pointing to robust refining margins and shareholder returns as key support factors. The bank maintained an Overweight-style stance in prior notes, framing Marathon Petroleum alongside large U.S. refiners such as Valero Energy and Phillips 66 in the current refining cycle. Finanzen100 aggregates recent analyst moves on Marathon Petroleum
All news and analysis on the Marathon Petroleum shares
Price data, background reports and further company news on Marathon Petroleum can be found bundled on the ad-hoc-news.de topic page and in the company’s investor relations section.
The refining and fuels business model
Marathon Petroleum operates one of the largest independent refining systems in the United States, with refineries positioned across the Gulf Coast and Midwest and a total crude oil refining capacity above 3 million barrels per day, according to company information. The group also runs extensive midstream and product logistics assets through MPLX as well as branded retail and wholesale marketing under the Marathon brand and other banners. Marathon Petroleum’s investor materials outline its refining and midstream footprint
Where the shares trade now
Marathon Petroleum shares (US56585A1025) most recently traded on the NYSE at about 247 US dollars on 2026-06-22, 21:59 (Eastern close), according to consolidated price data.
Key data on the Marathon Petroleum shares
- Company: Marathon Petroleum Corporation
- ISIN: US56585A1025
- WKN: A1JEXK
- Ticker: MPC
- Trading venue: NYSE
- Price (as of 2026-06-22, 21:59): 247.13 USD
- Market cap: 136 billion USD (as of 2026-06-22)
- Sector / industry: Energy - Oil & Gas Refining & Marketing
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Historical performance is not a reliable indicator of future results. Readers should conduct their own research and, where appropriate, consult a qualified financial advisor.
